Domus Biotechnologies is a 2018 founded biotechnology company, developing and marketing DNA transposition products. The company was founded by researchers, who have decades of experience in biotechnology and transposition technology. Domus offers products that are based on the transposition system of bacteriophage Mu. The minimal-component in vitro system, which forms the basis of the Mu-based DNA transposition technology, was originally developed by the researchers of the company. Our goal at Domus, is to offer easy to use products with superior efficiency, for more efficient and effective DNA manipulation and genome modification.